Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   


Term:EC [ribosyldihydronicotinamide dehydrogenase (quinone)] inhibitor
go back to main search page
Accession:CHEBI:77020 term browser browse the term
Definition:An EC 1.10.99.* (oxidoreductases acting on diphenols and related substances as donors, other acceptors) inhibitor that interferes with the action of ribosyldihydronicotinamide dehydrogenase (quinone), EC
Synonyms:related_synonym: 1-(beta-D-ribofuranosyl)-1,4-dihydronicotinamide:quinone oxidoreductase inhibitor;   1-(beta-D-ribofuranosyl)-1,4-dihydronicotinamide:quinone oxidoreductase inhibitors;   EC [ribosyldihydronicotinamide dehydrogenase (quinone)] inhibitors;   EC inhibitor;   EC inhibitors;   N-ribosyldihydronicotinamide dehydrogenase (quinone) inhibitor;   N-ribosyldihydronicotinamide dehydrogenase (quinone) inhibitors;   NAD(P)H:quinone oxidoreductase-2 inhibitor;   NAD(P)H:quinone oxidoreductase-2 inhibitors;   NAD(P)H:quinone oxidoreductase2 inhibitor;   NAD(P)H:quinone oxidoreductase2 inhibitors;   NQO2 inhibitor;   NQO2 inhibitors;   NRH:quinone oxidoreductase 2 inhibitor;   NRH:quinone oxidoreductase 2 inhibitors;   QR2 inhibitor;   QR2 inhibitors;   quinone reductase 2 inhibitor;   quinone reductase 2 inhibitors
 xref: Wikipedia:Ribosyldihydronicotinamide_dehydrogenase_(quinone)

show annotations for term's descendants       view all columns           Sort by:

Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 19734
    role 19680
      biological role 19678
        biochemical role 19177
          enzyme inhibitor 18082
            EC 1.* (oxidoreductase) inhibitor 16477
              EC 1.10.* (oxidoreductase acting on diphenols and related substances as donors) inhibitor 4252
                EC 1.10.99.* (oxidoreductases acting on diphenols and related substances as donors, other acceptors) inhibitor 3999
                  EC [ribosyldihydronicotinamide dehydrogenase (quinone)] inhibitor 3999
                    dabigatran + 8
                    quercetin + 3997
paths to the root


RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.